Absorption, distribution, metabolism and excretion of the biomaterials used in Nanocarrier drug delivery systems
- PMID: 31255595
- DOI: 10.1016/j.addr.2019.06.008
Absorption, distribution, metabolism and excretion of the biomaterials used in Nanocarrier drug delivery systems
Abstract
Nanocarriers (NCs) are a type of drug delivery system commonly used to regulate the pharmacokinetic and pharmacodynamic properties of drugs. Although a wide variety of NCs has been developed, relatively few have been registered for clinical trials and even fewer are clinically approved. Overt or potential toxicity, indistinct mechanisms of drug release and unsatisfactory pharmacokinetic behavior all contribute to their high failure rate during preclinical and clinical testing. These negative characteristics are not only due to the NCs themselves but also to the materials of the drug nanocarrier system (MDNS) that are released in vivo. In this article, we review the main analytical techniques used for bioassay of NCs and MDNS and their pharmacokinetics after administration by various routes. We anticipate our review will serve to improve the understanding of MDNS pharmacokinetics and facilitate the development of NC drug delivery systems.
Keywords: Bioassay; Drug delivery systems; Nanocarriers; Nanoparticles; Pharmacodynamics; Pharmacokinetics.
Copyright © 2019 Elsevier B.V. All rights reserved.
Similar articles
-
Absorption, distribution, metabolism, and excretion of nanocarriers in vivo and their influences.Adv Colloid Interface Sci. 2020 Oct;284:102261. doi: 10.1016/j.cis.2020.102261. Epub 2020 Sep 6. Adv Colloid Interface Sci. 2020. PMID: 32942181 Review.
-
The fate of nanocarriers as nanomedicines in vivo: important considerations and biological barriers to overcome.Curr Med Chem. 2013;20(22):2759-78. doi: 10.2174/0929867311320220003. Curr Med Chem. 2013. PMID: 23627938 Review.
-
Development of highly efficient nanocarrier-mediated delivery approaches for cancer therapy.Cancer Lett. 2016 Apr 28;374(1):31-43. doi: 10.1016/j.canlet.2016.01.050. Epub 2016 Feb 6. Cancer Lett. 2016. PMID: 26854717 Review.
-
Absorption, pharmacokinetics and disposition properties of solid lipid nanoparticles (SLNs).Curr Drug Metab. 2012 May 1;13(4):447-56. doi: 10.2174/138920012800166553. Curr Drug Metab. 2012. PMID: 22443539 Review.
-
Pharmacokinetics and in vivo fate of drug loaded chitosan nanoparticles.Curr Drug Metab. 2012 May 1;13(4):364-71. doi: 10.2174/138920012800166580. Curr Drug Metab. 2012. PMID: 22443533 Review.
Cited by
-
Recent Advances in Micro- and Nano-Drug Delivery Systems Based on Natural and Synthetic Biomaterials.Polymers (Basel). 2023 Nov 28;15(23):4563. doi: 10.3390/polym15234563. Polymers (Basel). 2023. PMID: 38231996 Free PMC article. Review.
-
Pharmacokinetics and tumor delivery of nanoparticles.J Drug Deliv Sci Technol. 2023 May;83:104404. doi: 10.1016/j.jddst.2023.104404. Epub 2023 Apr 5. J Drug Deliv Sci Technol. 2023. PMID: 38037664 Free PMC article.
-
Janus Dendrimers to Assess the Anti-HCV Activity of Molecules in Cell-Assays.Pharmaceutics. 2020 Nov 7;12(11):1062. doi: 10.3390/pharmaceutics12111062. Pharmaceutics. 2020. PMID: 33171841 Free PMC article.
-
Polymeric Nanoparticles Controlled by On-Chip Self-Assembly Enhance Cancer Treatment Effectiveness.Adv Healthc Mater. 2020 Nov;9(22):e2001633. doi: 10.1002/adhm.202001633. Epub 2020 Oct 18. Adv Healthc Mater. 2020. PMID: 33073526 Free PMC article.
-
Lactosylated IR820/DOX Co-Assembled Nanodrug for Synergetic Antitumour Therapy.Int J Nanomedicine. 2020 Jun 22;15:4431-4440. doi: 10.2147/IJN.S247617. eCollection 2020. Int J Nanomedicine. 2020. PMID: 32606687 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources